<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT932-7744</title>
	</head>
	<body>
		<main>
			<p>930521 FT  21 MAY 93 / International Company News: New drug sales help net at Ono climb by 15% ONO Pharmaceutical, a medium-sized Japanese drug maker, announced a 21.2 per cent increase, to Y36.3bn (Dollars 327.02m), in pre-tax profits for the year to March. It attributed the rise to sales of new drugs. Net profits rose 15.5 per cent to Y15.5bn. Sales grew 19.9 per cent to Y95.1bn as a result of solid sales of Kinedak, its remedy for diabetes, and Vega, its anti-asthmatic compound. The company is to raise dividends by Y6 to Y20 per share for the last fiscal year in tandem with the increase in profits and sales. The Osaka-based company expects pre-tax profits to climb 3.2 per cent to Y37.5bn for the current financial year. Taisho Pharmaceutical said pre-tax profits rose 1 per cent to Y54.3bn last year. Net profits increased 1.5 per cent to Y28.3bn. Sales rose 7.3 per cent to Y204bn against the last fiscal year, on steady sales of antibiotic and new tonic drinks.</p>
		</main>
</body></html>
            